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approach was used to study the inhibition of IN by 5CITEP inhibitor in presence of divalent cations
(Mg2+ or Mn2+). In addition, the main interactions occurring in 5CITEP-IN complex and the inﬂuence of
divalent cations (Mg2+ or Mn2+) in enzymatic inhibition were investigated using B3LYP/6-31+G(d,p)/
MM. The results suggest that the Asp64, Asp116 and four crystal water molecules plays a crucial role
in cation (Mg2+ or Mn2+) coordination sphere.
 2013 Elsevier B.V. All rights reserved.1. Introduction
Approximately two-thirds of the elements in the periodic table
can be categorized as metals [1], and the ionic forms of these ele-
ments are often associated with catalytic or regulatory activities of
proteins. Currently, the Protein Data Bank (PDB) contains approxi-
mately 25,000 structure hits, which contain at least a metal ion [2].
The metal ions play essential roles in about one third of enzymes
[3] essential for fundamental chemical life processes [4–7]. There-
fore, a detailed knowledge of these two issues could provide guide-
lines to the design of potent inhibitors or drug molecules for
metalloproteins, as the HIV-1 integrase (IN), a promising target
in anti-AIDS drug design due mainly its important role in the HIV
life cycle [8].
HIV-1 IN belongs to a class of nucleotide-related enzymes
including nucleases, polymerases, and polynucleotidyl transferases
[9,10]. These enzymes commonly have an acidic amino residue
cluster in the active sites, which are known to be essential for their
native functions. The main residues are thought to hold metal
cofactors, which directly catalyze hydrolysis and/or transesteriﬁca-
tion reactions of phosphoryl esters of nucleotides according to a
two-metal-ion catalysis mechanism proposed. Then, to perform
its role, the cofactor ions such as Mg2+ or Mn2+ are required by
HIV-1 IN [11–13].
The experimental determined HIV-1 IN structure is catalytic
triad conserved Asp64, Asp116, and Glu152 that is held by a metal
ion, which is thought to be Mg2+ under physiological condition
[14]. The Mg2+ ion was frequently found to be coordinated by the
carboxylic groups of Asp64 and Asp116 of the catalytic triad in
crystal structures of the HIV-1 IN core domain [15]. Speciﬁcin vitro assays have been developed for both reactions by using re-
combinant IN, a 21-mer DNA substrate representing the U5 region
of the HIV-1 long terminal repeat (LTR) regions, and metal cofac-
tors such as Mg2+ or Mn2+ [16]. These in vitro assays have been
used to discover a plethora of IN inhibitors from diverse chemical
classes [17–20]. However, the mechanisms by which a metal ion is
selected by a protein and subsequently regulates protein function
are generally not well understood [21]. Therefore, a detailed
knowledge of coordination forms of amino acid side chains around
each metal ion could help on the plausibility of a mechanism
involving metal ion catalysis of hydrolysis in the hammerhead
ribozyme and includes an Mg2+ ion with a complete ﬁrst-coordina-
tion sphere to represent the immediate environment of this diva-
lent metal ion at the active site. Herein, we have employed
hybrid quantum mechanics/molecular mechanics (QM/MM)
approach and molecular dynamics (MD) simulations to study the
difference in inhibitory potency of 1-(5-chloroindol-3-yl)-3-hydro-
xy-3-(2H-tetrazol-5-yl)-propenone (5CITEP) inhibitor in complex
with HIV-1 IN–Mg2+ and HIV-1 IN–Mn2+.
2. Computational methods
2.1. QM/MM simulations
The 3D structure of HIV-1 IN was obtained from the Protein
Data Bank (PDB accession code 1QS4) which is complex with
5CITEP inhibitor that binds centrally in the active site of the integr-
ase andmakes a number of close contacts with the protein. In vitro,
5CITEP inhibits integration by selectively blocking strand transfer
reaction, and have been proposed to bind to a divalent metal ion
in the integrase catalytic site [22,23] (and this binding is metal
dependent [24]. Since the standard pKa values of ionizable groups
can be shifted by local protein environments [25], a rapid empirical
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at pH = 7 was carried out using the empirical PROPKA 3.1 program
of Jensen and co-workers for protein-ligand calculations [26]. The
starting molecular mechanical simulations of the HIV-1 IN
complexes with 5CITEP and Mg2+/Mn2+ were performed using
the AMBER 12 software [27]. The AMBER force ﬁeld 99SB [28]
and the general AMBER force ﬁeld (GAFF) [29] were employed to
describe the inhibitor-protein and inhibitor-solvent behavior,
respectively. The RESP method was used to calculate the inhibitors
charges applying HF/6-31G⁄ theory quantum level using Gaussian
03 [30] package. The complexes were prepared with Leap program.
A cubic box of TIP3P water molecules [31] extending 12 Å outside
the protein on each side, was used for each complex structure
(140  135  120 Å). The starting complexes prepared as described
earlier were ﬁrstly minimized with 10,000 steps of conjugate
gradient energy minimization and a constrain of 10 kcal/mol. Å2
applied to the solute (protein, cation and inhibitor) using the san-
der module of AMBER 12 software [27]. Then, the IN complexes
were energyminimized and then gradually heated to 300 K over
50 ps with constrain of 2.0 kcal/mol. Å2 applied to the solute. The
systems were equilibrated for 300 ps before the production stage.
All minimizations and heating simulations employed a non-
bonded cutoff of 8 Å. The time step was set to 2 fs and all bonds
involving hydrogen atoms were constrained using the SHAKE algo-
rithm [32] during the classical minimizations and heating simula-
tions. Then, both IN complexes were submitted to QM/MM
simulations [33]. All QM/MM calculations were performed using
AMBER 12 software [27] coupled with Gaussian 03 package [30],
at step all calculations were performed with a larger cutoff than
the system size thus effectively included all interactions. The QM
subsystem was treated using DFT theoretical level (B3LYP/6-
31+G(d,p) basis set) and to describe the MM subsystem, the AM-
BER force ﬁeld 99SB [28] was applied. Particularly, the classical
MM parameters for Mn2+ [34] was obtained in AMBER parameters
database created by Bryce Group. In the QM/MM calculations, the
5CITEP inhibitor, Asp64 and Asp116 catalytic residues, four water
crystal molecules and divalent cation (Mg2+ and Mn2+) (Scheme 1)
were included in the QM subsystem and the rest of system was
treated by MM method. Furthermore, after QM/MM optimizations,
the Molecular Electrostatic Potential (MEP) surface for both HIV-
1IN systems were plotted using B3LYP/6-31+G (d,p) basis set, com-
puted under the effect of the protein environment, using Gaussian
03 package [30] and Molekel visual software [35].Scheme 1. QM/MM system representation for HIV-1 IN–5CITEP and divalent cation
complex. Where M2+ represents Mg2+ or Mn2+ cations. HQ represent atom link (H
atom).3. Results and discussion
3.1. QM/MM simulations
The QM/MM approach [33] has been used successfully for a de-
tailed understanding of IN-inhibitor interaction [36,37], HIV-1 IN
catalytic mechanism [38] and the ion function in Glycosyltransfer-
ase mechanism [39], as well in others biological systems [40]. Re-
cently, classical molecular dynamic simulations have been carried
out for HIV-1 IN with Mg2+ ion [41,42]. In this study, the QM/MM
approach was used to investigate the inﬂuence of cofactors in HIV-
1 IN–5CITEP complexes. The ﬁrst system contain the Mg2+ ion che-
lated by Asp64, Asp116, and water molecules, while the second
system, the Mg2+ was replaced by Mn2+ ion.
The binding of the 5CITEP to HIV-1 IN can be metal dependent.
The observation that the acid substituent confers metal depen-
dence on this inhibitor suggests divalent metal may be required
for binding. To address whether binding is metal dependent, com-
plexes were studied in the presence and absence of Mg2+ or Mn2+
[24]. Moreover, substitutions in several amino acids near the metal
coordinating residues Asp64 e Glu152 of integrase confer resis-
tance to 5CITEP inhibitor in Mg2+ but not Mn2+ [43]. In vitro, the
integrase requires Mg2+ or Mn2+ for enzymatic activity. Experimen-
tal results show that 5CITEP has different inhibition activities when
the IN enzyme is in complex Mg2+ or Mn2+, this inhibitor is more
potent in the presence of Mn2+ ion [44].
In the crystal structure of core domain IN complex with 5ClTEP,
the Mg2+ ion was coordinated to two of the catalytic triad residues,
Asp64, and Asp116, and four water molecules (named OW1, OW2,
OW3 and OW4) [45]. In this study, the theoretical level (B3LYP/6-
31+G(d,p) basis set) was applied to elucidate the main difference
on IN inhibition by 5CITEP, when this enzyme is in complex with
Mg2+ or Mn2+. After all optimization steps (Computational methods
section) the last structure for each system (IN–5CITEP–Mg2+ and
IN–5CITEP–Mn2+) was analyzed (Figure 1). A theoretical study
about the catalytic mechanism of HIV-1 IN [38] had shown the
importance of a water molecule during the last step of reaction
mechanism, where a proton is transferred from a water molecule
(OW1) to carboxyl group of Asp64. During the optimization the
distance between the O atom of WO1 and Mn2+ ion (Figure 1a) in-
crease when compared with Mg2+ (Figure 1b), consequently WO1
and Asp64 have tighter hydrogen bond in IN–5CITEP–Mg2+ than in
the IN–5CITEP–Mn2+ complex, which may be suggest that barrier
for the proton transfer from OW1 to Asp64 in the IN–5CITEP–
Mn2+ complex could be higher than IN–5CITEP–Mg2+. This hypoth-
esis could explain why the 5CITEP inhibitor becomes more potent
when it is in complex with Mn2+ ion, as reveals in experimental
studies [44]. On the other hand, a theoretical mechanism using
snapshots frommolecular dynamics simulations will be performed
in the future, in order to evaluate this hypothesis. In addition, the
catalytic residues Asp64 and Asp116 maintain similar distances
between O atoms of the carboxyl groups and the ions chelated (Fig-
ure 1).3.2. Molecular electrostatic potential
The molecular electrostatic potential (MEP) provides important
information about nuclear and electronic charge distribution of a
given molecule. The MEP has been used primarily for predicting
sites and relative reactivities towards electrophilic attack and in
studies of biological recognition and hydrogen bonding interac-
tions [46]. It provides a visual method to understand the relative
polarity of a molecule and serves as a useful tool to explain hydro-
gen bonding, reactivity and structure–activity relationship of mol-
ecules, including biomolecules and drugs [37,47]. Herein, the MEP
Figure 1. Position adopted after QM/MM simulations for IN–5CITEP complex. (a) IN–5CITEP–Mg2+ and (b) IN–5CITEP–Mn2+.
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ment and were derived from B3LYP/6-31+G (d,p) theoretical level
calculations using Gaussian 03 [30] and visualised in Molekel vi-
sual software [35]. These surfaces correspond to the isodensity va-
lue of 0.002 a.u. The different values of the electrostatic potential at
the surface are represented by different colors; red represents re-
gions of most negative electrostatic potential, blue represents re-
gions of most positive electrostatic potential and green
represents regions of zero potential.
In the previous section it was commented that the difference in
potency of 5CITEP inhibitor in both complexes (IN–5CITEP–Mg2+
and IN–5CITEP–Mn2+), was attributed to the coordination of water
around the divalent cations. The OW1 water molecule interacts
with the carboxyl group of Asp64 residue forming a hydrogen bond
In the IN–5CITEP–Mg2+ complex (Figure 1a). Whereas, in IN–5CI-
TEP–Mn2+ complex, it interacts with the indole part of the inhibitor
through hydrogen-p interaction (Figure 1b). The charge transfer
occurring in IN–5CITEP–Mn2+ complex may be elucidated visualiz-
ing by MEP (Figure 2b).
In the IN–5CITEP–Mg2+ complex (Figure 2a), the 5-chloro-1H-
indole ring inhibitor has more electronegative region than IN–5CI-
TEP–Mn2+ (Figure 2b). The nucleophilic regions for both complexes
can be found around the divalent cations, in accordance with
chemical knowledge. The positive region around the divalent
cations allow the formation of coordination sphere by water crystal
and carboxyl groups of Asp catalytic residues. The electrophilic re-
gions for both complexes can be found mainly around tetrazole
ring inhibitor. These MEPs are in accordance with our resultsFigure 2. Molecular Electrostatic Potential MEP surfaces of (a) IN–5CITEP–Mg2+ compl
(positive) to red (negative).regarding contributions of cation, aspartic residues and water crys-
tal molecules to 5CITEP inhibitor interaction and may be used as
templates for design of new inhibitors against HIV-1 IN. The 5CITEP
key charges (RESP) can be found in Supporting information.
3.3. HOMO and LUMO frontier orbitals
Both the highest occupied molecular orbital (HOMO) and the
lowest unoccupied molecular orbital (LUMO) and their properties
such as energy are very useful to explain the chemical reaction.
While the HOMO energy is directly related to the ionization poten-
tial, LUMO energy is directly related to the electron afﬁnity [48].
The surface graphs for the frontier orbitals were plotted to under-
stand the bonding scheme of HIV-1 IN complex with 5CITEP inhib-
itor and Mg2+/Mn2+ ion in the catalytic core (Figure 3). The energy
difference between HOMO and LUMO orbital, which is named as
energy gap, is a critical parameter in determining molecular elec-
trical transport properties because it is a measure of electron con-
ductivity [48,49]. The features of the HOMO and LUMO of the title
molecule with gap values can be seen in Figure 3. In the HOMO, the
charge density is mainly accumulated on the indole part and
hydrochloride group. However, in case of the LUMO, more charge
density moves to the divalent cations and its coordination sphere.
It can then be inferred that the divalent metal cation acts as a Lewis
acid and its presence is essential in tuning the reaction, in lowering
the activation barrier, and in catalyzing the desired bond cleavage,
as experiments both in vitro and in vivo seem to suggest [24,44]
and previous theoretical study [38].ex (b) IN–5CITEP–Mn2+ complex. The increase of negative charges goes from blue
Figure 3. HOMO and LUMO frontier orbitals of (a) IN–5CITEP–Mg2+ complex (b) IN–5CITEP–Mn2+ complex, using DFT theoretical level B3LYP with 6-31+G(d,p) basis set .
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(eHOMO) is referred to as IP (Ionization potential) by Koopmann’s
theorem and the LUMO energy (eLUMO) has been applied to esti-
mate the electron afﬁnity (EA) [50]. Therefore, eHOMO  IP and
eLUMO  EA, respectively. Appling these theories in the complexes
studied here, the EA for IN–5CITEP–Mg2+ (2.97 eV) is higher than
IN–5CITEP–Mn2+ (2.83 eV), as the divalent cation acts as Lewis
acid, it also may be inﬂuence the catalysis.4. Conclusions
QM/MM approach has been used to study the inﬂuence of diva-
lent cations (Mg2+ and Mn2+) in the IN–5CITEP complexes. The re-
sults suggest that the Asp64 and Asp116 plus four crystal water
molecules plays a crucial role in cation coordination sphere, which
is in accordance with previous experimental proposal. After QM/
MM optimizations, the hydrogen bond between OW1 and Asp64
is stronger in the IN–5CITEP–Mg2+ than in the IN–5CITEP–Mn2+
complex, which could explain why the 5CITEP inhibitor becomes
more potent when it is in complex with Mn2+ ion, as observed in
experimental studies. Moreover, the MEP and HOMO/LUMO calcu-
lations that determined the electrostatic contribution and reactive
region, respectively, show the main differences of charge transfer
involved in each complex. Finally, the results are expected to pro-
vide useful information for the rational design of new HIV-1 IN
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